National Comprehensive Cancer Network

During this interactive online program, pharmaceutical and biotechnology professionals are given the rare opportunity to view the oncology space, its future and its current operational issues from the provider, advocacy, and payer perspectives. Through this pharmaceutical and biotech training program, participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology while gathering valuable insights into developing effective strategies for navigating the cancer care ecosystem. Pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.

Please check back often for additional updates regarding this program. If you have any questions, please contact Erin Green, Business Development Specialist.

MODERATOR

Clifford Goodman, PhD
Senior Vice President
The Lewin Group

CURRICULUM*

12:30 – 12:35 PM	Welcome
12:35 – 1:55 PM	Module I: Oncology Medical Home: Perspectives on Evolution, Impact & Future State Moderator Clifford Goodman, PhD Senior Vice President The Lewin Group Russell J. Hoverman, MD, PhD Vice President, Quality Programs, Medical Director, Manage Care Texas Oncology Medical Director of Managed Care US Oncology Network Ron Kline, MD, FAAP Chief Medical Officer \| Healthcare and Insurance US Office of Personnel Management Formerly, Clinical Lead for CMS' Oncology Care Model Michael Kolodziej, MD Vice President and Chief Innovation Officer ADVI Brady Luby, MS Manager, Contracting & Payor Relations Robert H. Lurie Comprehensive Cancer Center of Northwestern University Barbara McAneny, MD, FASCO, MACP Chief Executive Officer & Immediate Past-President, American Medical Association New Mexico Oncology Hematology Consultants, Ltd Maya Said, Sc.D. Founder & Chief Executive Officer Outcomes4Me
1:55 – 3:25 PM	Module II: Pathways: A View Across Developers and Stakeholders Alan Balch, PhD Chief Executive Officer Patient Advocate Foundation Robert W. Carlson, MD Chief Executive Officer National Comprehensive Cancer Network Andrew Hertler, MD, FACP Chief Medical Officer New Century Health Russell J. Hoverman, MD, PhD Vice President, Quality Programs, Medical Director, Managed Care Texas Oncology Medical Director of Managed Care US Oncology Network Zachary Lorinc Senior Director of Operations Elsevier, Clinical Path
3:25 – 3:30 PM	Closing Remarks Gary J. Weyhmuller, MBA, SPHR Executive Vice President, Chief Operating Officer National Comprehensive Cancer Network

*Curriculum subject to change.

INTENDED AUDIENCE

Professionals from advocacy, marketing, medical affairs, clinical research, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.

Customize your own NCCN Academy curriculum.

NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.

Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.